From Polypharmacology to Target Specificity: The Case of PARP Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|13|23|2939-2954

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.23, 2013-12, pp. : 2939-2954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis Inhibitors. Drug Selectivity and Target Specificity

By  

Current Pharmaceutical Design, Vol. 13, Iss. 27, 2007-09 ,pp. : 2795-2809

Bentham Science Publishers

Access to resources Recommend Favorite

Development of PARP inhibitors in oncology

By Rodon Jordi   Iniesta Maria D   Papadopoulos Kyriakos  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 31-43

Informa Healthcare

Access to resources Recommend Favorite

Discussion of PARP inhibitors in cancer therapy

By Wielgos Monica   Yang Eddy S  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. : 755-766

Future Science

Access to resources Recommend Favorite

PARP inhibitors in cancer therapy: an update

By Papeo Gianluca   Casale Elena   Montagnoli Alessia   Cirla Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 503-514

Informa Healthcare

Access to resources Recommend Favorite

Parp Inhibitors for the Treatment of Ovarian Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 9, 2018-11 ,pp. : 877-893

Bentham Science Publishers

Access to resources Recommend Favorite